Singular Genomics Systems, Inc. – NASDAQ:OMIC
Founder-led company
Singular Genomics Systems stock price today
$19.988
+0.38
+1.98%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in 35 minutes
Singular Genomics Systems stock price monthly change
+124.26%
month
Singular Genomics Systems stock price quarterly change
+124.26%
quarter
Singular Genomics Systems stock price yearly change
+4294.62%
year
Singular Genomics Systems key metrics
Market Cap | 48.35M |
Enterprise value | 63.32M |
P/E | -0.81 |
EV/Sales | 82.77 |
EV/EBITDA | -0.75 |
Price/Sales | 102.93 |
Price/Book | 0.30 |
PEG ratio | -0.02 |
EPS | -1.31 |
Revenue | 2.49M |
EBITDA | -90.06M |
Income | -96.21M |
Revenue Q/Q | -48.78% |
Revenue Y/Y | 52.94% |
Profit margin | -11879.61% |
Oper. margin | -12220.52% |
Gross margin | -3.14% |
EBIT margin | -12220.52% |
EBITDA margin | -3617.07% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSingular Genomics Systems stock price history
Singular Genomics Systems stock forecast
Singular Genomics Systems financial statements
| Jun 2023 | 505K | -25.57M | -5064.95% |
|---|---|---|---|
| Sep 2023 | 462K | -22.36M | -4839.83% |
| Dec 2023 | 1.08M | -23.24M | -2150.69% |
| Mar 2024 | 442K | -25.02M | -5661.54% |
| Sep 2025 | 7.81M | -21.70M | -277.7% |
|---|---|---|---|
| Oct 2025 | 7.81M | -654.53M | -8373.47% |
| Dec 2025 | 9.69M | -658.32M | -6792.64% |
| Mar 2026 | 12.89M | -15.73M | -122% |
Analysts Price target
Financials & Ratios estimates
| 2024-03-18 | -0.34 | -0.32 |
|---|---|---|
| 2024-05-14 | -0.35 | -10.21 |
| Jun 2023 | 283978000 | 65.59M | 23.1% |
|---|---|---|---|
| Sep 2023 | 284518000 | 85.49M | 30.05% |
| Dec 2023 | 265467000 | 86.46M | 32.57% |
| Mar 2024 | 239101000 | 82.40M | 34.46% |
| Jun 2023 | -19.99M | -35.08M | 618K |
|---|---|---|---|
| Sep 2023 | -16.81M | -24.70M | 0 |
| Dec 2023 | -18.90M | 651K | 72K |
| Mar 2024 | -23.70M | 31.57M | 0 |
Singular Genomics Systems alternative data
| Aug 2023 | 276 |
|---|---|
| Sep 2023 | 269 |
| Oct 2023 | 269 |
| Nov 2023 | 269 |
| Dec 2023 | 284 |
| Jan 2024 | 284 |
| Feb 2024 | 284 |
| Apr 2024 | 255 |
| May 2024 | 255 |
| Jun 2024 | 255 |
| Jul 2024 | 255 |
Singular Genomics Systems other data
21.21%
-31.00%
of OMIC is owned by hedge funds
38
-39
15.09M
-22.08M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2024 | 122416 | 175 |
| Nov 2024 | 0 | 695 |
| Dec 2024 | 0 | 180 |
| Quarter | Transcript |
|---|---|
| Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 18 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Andrew Spaventa (1985) Founder, Chief Executive Officer & Chairperson of the Board | $474,560 |
Dr. Eli N. Glezer Ph.D. (1969) Founder & Chief Scientific Officer | $380,620 |
Mr. Dalen Meeter (1978) Senior Vice President of Fin. | $315,070 |
-
What's the price of Singular Genomics Systems stock today?
One share of Singular Genomics Systems stock can currently be purchased for approximately $19.99.
-
When is Singular Genomics Systems's next earnings date?
Unfortunately, Singular Genomics Systems's (OMIC) next earnings date is currently unknown.
-
Does Singular Genomics Systems pay dividends?
No, Singular Genomics Systems does not pay dividends.
-
How much money does Singular Genomics Systems make?
Singular Genomics Systems has a market capitalization of 48.35M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 280.52% to 2.91M US dollars. Singular Genomics Systems made a loss 94.82M US dollars in net income (profit) last year or -$10.21 on an earnings per share basis.
-
What is Singular Genomics Systems's stock symbol?
Singular Genomics Systems, Inc. is traded on the NASDAQ under the ticker symbol "OMIC".
-
What is Singular Genomics Systems's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Singular Genomics Systems?
Shares of Singular Genomics Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Singular Genomics Systems's key executives?
Singular Genomics Systems's management team includes the following people:
- Mr. Andrew Spaventa Founder, Chief Executive Officer & Chairperson of the Board(age: 40, pay: $474,560)
- Dr. Eli N. Glezer Ph.D. Founder & Chief Scientific Officer(age: 56, pay: $380,620)
- Mr. Dalen Meeter Senior Vice President of Fin.(age: 47, pay: $315,070)
-
Is Singular Genomics Systems founder-led company?
Yes, Singular Genomics Systems is a company led by its founders Mr. Andrew Spaventa and Dr. Eli N. Glezer Ph.D..
-
How many employees does Singular Genomics Systems have?
As Jul 2024, Singular Genomics Systems employs 255 workers.
-
When Singular Genomics Systems went public?
Singular Genomics Systems, Inc. is publicly traded company for more then 4 years since IPO on 27 May 2021.
-
What is Singular Genomics Systems's official website?
The official website for Singular Genomics Systems is singulargenomics.com.
-
Where are Singular Genomics Systems's headquarters?
Singular Genomics Systems is headquartered at 10931 North Torrey Pines Road, La Jolla, CA.
-
How can i contact Singular Genomics Systems?
Singular Genomics Systems's mailing address is 10931 North Torrey Pines Road, La Jolla, CA and company can be reached via phone at 858 333 7830.
Singular Genomics Systems company profile:
Singular Genomics Systems, Inc.
singulargenomics.comExchange:
NASDAQ
Full time employees:
255
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.
10931 North Torrey Pines Road
La Jolla, CA 92037
La Jolla, CA 92037
CIK: 0001850906
ISIN: US82933R1005
CUSIP: 82933R100
